Long-term experience with Sandimmun Neoral: results in de novo and stable renal transplant patients after 24-month treatment. The German Neoral Study Group

Transplant Proc. 1997 Nov;29(7):2945-7. doi: 10.1016/s0041-1345(97)00739-2.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Creatinine / blood
  • Cyclosporine / administration & dosage
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use*
  • Dosage Forms
  • Double-Blind Method
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Germany
  • Graft Rejection / epidemiology
  • Graft Rejection / prevention & control
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / physiology
  • Time Factors

Substances

  • Dosage Forms
  • Immunosuppressive Agents
  • Cyclosporine
  • Creatinine